Medical devices, healthcare technology and the business of care
510(k) clearance · K262207

Cemented Plus Abutment

Unidental Co., Ltd. · Decision date Sep 23, 2026

MEDTECHLEDGER EXPLANATIONK262207

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on 2026-09-23 for the Cemented Plus Abutment, submitted by Unidental Co., Ltd. of Gwangmyeong-Si, Republic of Korea, under 510(k) number K262207. The device is classified as an endosseous dental implant abutment (product code NHA, regulation 872.3630) in the Dental specialty and review panel. The application was received on 06/30/2026 and is listed as a traditional 510(k) not reviewed by a third party.

SESE denotes 510(k) clearance to market, not premarket approval. The record identifies the reviewed item as the Cemented Plus Abutment and describes it as an endosseous dental implant abutment, Class II; the available excerpts do not specify individual components, materials, or any change relative to a predicate device. The public summary field is empty, so the basis for the equivalence determination, including performance data and any clinical information, remains unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Sep 23, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262207
Regulatory pathway
510(k) premarket notification
Product code
NHA
Decision code
SESE
Decision date
Sep 23, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Abutment, Implant, Dental, Endosseous.

Product code
NHA
FDA device class
2

FDA decision timeline

  1. K262207 received

    Application receipt date recorded by FDA.

  2. K262207 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NHA

Product / regulatory recordCompanyPathwayDecision dateSource
Elos Medtech Pinol A/S510(k) clearanceSep 30, 2026FDA
ZimVie US Corp, LLC510(k) clearanceSep 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Unidental Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Gwangmyeong-Si

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records